Core Viewpoint - The company, Jiarong Technology, is planning to acquire control of Hangzhou Lanan Technology through a share issuance, leading to a significant asset restructuring and potential related party transactions [1][2]. Group 1: Acquisition Details - Jiarong Technology has signed a letter of intent with major shareholders of Hangzhou Lanan to purchase all shares through a share issuance [1]. - The transaction is expected to be completed within 10 trading days, with a disclosure of the transaction plan [1]. - The acquisition is anticipated to result in the major counterpart holding over 5% of Jiarong Technology post-transaction, constituting a related party transaction [1]. Group 2: Financial Performance - For the first three quarters, Jiarong Technology reported revenue of 362 million, a year-on-year decrease of 7.53%, while net profit attributable to shareholders increased by 12.95% [2]. - The company's net profit is projected to decline over the next three years, with estimates of 107 million, 58.07 million, and 50.20 million for 2022, 2023, and 2024 respectively [2]. - Jiarong Technology's gross profit margin stands at 41.18%, ranking favorably among peers in the water environment engineering equipment sector [2]. Group 3: Hangzhou Lanan Technology Background - Hangzhou Lanan, established in 2009, specializes in the research, production, and sales of ion exchange membranes and related equipment, which complements Jiarong Technology's membrane technology business [2]. - The company previously attempted to go public but withdrew its application due to regulatory issues, including financial misreporting and internal control failures [3]. - Hangzhou Lanan's overall valuation is estimated at approximately 1.28 billion based on a recent share transfer [2].

值得注意的是，杭州蓝然曾"带病"闯关创业板IPO。2022年6月，杭州蓝然向深圳证券交易所递交了创业 板上市申请材料，并获得受理。但深交所现场督导发现，该公司存在严重的收入跨期确认问题，2022年 12月，杭州蓝然撤回了申请，终止了该次IPO。 2023年4月，深交所发布《发行上市审核动态》，将杭州蓝然作为典型监管案例予以警示。 嘉戎技术主营业务为特种膜分离材料、膜分离装备等产品及高浓度污废水处理服务，市场覆盖垃圾渗滤 液、工业废水等领域。2025年前三季度，公司实现营业收入3.62亿元，同比下降7.53%；归属于上市公 司股东的净利润5930.12万元，同比增长12.95%。 公司预计10个交易日内披露交易方案。若未能在期限内披露，公司最晚将于2025年12月1日复牌并终止 筹划事项，同时披露停牌期间相关工作进展。 杭州蓝然的产品线与嘉戎技术的膜技术业务存在协同性和互补性。公开资料显示，杭州蓝然以电渗析技 术研发与应用为核心，主要从事离子交换膜及组件、电渗析相关设备的研发、生产、销售及技术服务。 此外，杭州蓝然的子公司衢州蓝然新材料有限公司已建立年产85万平离子交换膜生产线；另一家子公司 杭州埃尔环保科技有 ...